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Purpose: Previous studies suggest one-third of breast cancer survivors (BCS) experience 
elevated fear of cancer recurrence (FCR) and that it remains stable. Most studies include 
long assessment intervals and aggregated group data. This study aimed to describe the 
individual trajectories of FCR when assessed monthly using both a statistical and 
descriptive approach.
Methods: Participants were curatively-treated BCS 0–5 years post-surgery. Questionnaire 
data were collected monthly for 12 months. Primary outcome was FCR [Cancer Worry 
Scale (CWS)]. For the descriptive approach, 218 participants were classified as low 
(CWS ≤ 13 at each assessment), high (CWS ≥ 14 at each assessment), or fluctuating 
FCR (CWS scores above and below cut-off). Latent class growth analysis (LCGA; n = 377) 
was conducted to identify trajectories over time.
Results: Around 58% of the women reported fluctuating CWS scores, 22% reported a 
consistently high and 21% consistently low course. Results of the LCGA confirmed the 
three-class approach including a stable high FCR group (13%), a low FCR group (40%), and 
a moderate FCR group (47%). Both the moderate and low scoring groups reported declining 
scores over time. Younger patients, higher educated patients, and those less satisfied with 
the medical treatment were more likely to belong to the moderate or high trajectory.
Conclusion: Assessed monthly, the majority of BCS report fluctuating levels of FCR. 
Stepped-care models should assess FCR on multiple occasions before offering 
tailored interventions.
Keywords: fear of cancer recurrence, individual trajectories, oncology, breast cancer survivors, Cancer Worry 
Scale, latent class growth analysis
Custers et al. Twelve Monthly Assessments of FCR
Frontiers in Psychology | www.frontiersin.org 2 November 2020 | Volume 11 | Article 580979
INTRODUCTION
Fear of cancer recurrence (FCR) is one of the most prevalent 
symptoms among breast cancer survivors (BCS), with a high 
need for support (Armes et al., 2009; Boyes et al., 2012; Willems 
et al., 2016). While some degree of FCR is normal and adaptive, 
higher levels of FCR are associated with distress, psychological 
symptoms, rumination, excessive frequent bodily-checking, lower 
quality-of-life, and functional impairment (Simard et al., 2013). 
The reported prevalence of at least moderate FCR among Dutch 
BCS ranges between 31 and 56% (Van den Beuken-van 
Everdingen et  al., 2008; Custers et  al., 2014). Intuitively, one 
might expect FCR to reduce over time due to psychological 
adjustment and diminishing objective risk of breast cancer 
recurrence. However, a proportion of long-term BCS continue 
to experience FCR many years after their cancer diagnosis. 
For example in a large sample (n  =  2,671) of German BCS, 
17% reported moderate to high levels of fear of recurrence 
when surveyed an average of 8  years after diagnosis (Koch 
et  al., 2014). While some attention has been given to studying 
the course and trajectories of distress (Henselmans et al., 2010; 
Lam et  al., 2012), mental and physical functioning (Helgeson 
et  al., 2004), and depressive symptoms (Stanton et  al., 2015) 
among BCS, the course of FCR has received relatively little 
attention in the literature to date.
Synthesis of existing literature on longitudinal data of FCR 
in BCS is complicated by the fact that a variety of instruments 
have been used to assess FCR, as well as the variation in the 
timing and number of data collection points. Two literature 
reviews including studies with mixed cancer types concluded 
that high FCR remains stable over time (Koch et  al., 2013; 
Simard et  al., 2013). Among 22 longitudinal studies of FCR, 
Simard and colleagues found the majority (n  =  18) reported 
either no change in FCR during the follow-up periods examined 
(3  months–6  years after end of treatment) or that there was 
an initial decrease of FCR with scores remaining stable thereafter. 
In a literature review by Koch et  al. (2013) of FCR in long-
term cancer survivors only two (Bowman et al., 2004; Langeveld 
et  al., 2004) out of eight (Deimling et  al., 2002; Bowman 
et al., 2004; Langeveld et al., 2004; Carver et al., 2006; Deimling 
et al., 2006a,b; Crespi et al., 2008; Skaali et al., 2009) longitudinal 
studies found that time since diagnosis was significantly associated 
with FCR, which the authors interpreted as evidence that FCR 
persists over an extensive period of time after the initial 
diagnosis without significant changes in intensity. Fifteen studies 
have examined the course of FCR exclusively among BCS with 
equivocal findings. In seven studies, FCR decreased over time 
(Bloom et  al., 2004; Lebel et  al., 2007; Armes et  al., 2009; 
Lebel et  al., 2009; Melchior et  al., 2013; Halbach et  al., 2016; 
Yang et  al., 2018). Four studies (Stanton et  al., 2002; Costanzo 
et  al., 2007; Sheppard et  al., 2009; Ashing et  al., 2017) found 
that FCR remained stable over time, and two studies (Rabin 
et al., 2004; Dunn et al., 2015) found an initial decrease followed 
by stabilization. One study, which assessed FCR at multiple 
time points in the month prior to and after a follow-up 
mammography, found an increase then decrease in FCR after 
a good (i.e., negative) test result and increase during the month 
following the mammography (McGinty et  al., 2016). Finally, 
one study reported stable levels of FCR in the first 6  months 
after surgery. After this period, older BCS reported decreasing 
levels of FCR whereas younger BCS reported an increase of 
FCR (Starreveld et  al., 2018). It is noteworthy, however, that 
most longitudinal studies of FCR reported changes in FCR 
based on the mean of FCR scores or prevalence of high FCR 
(i.e., score above a cut-off on a questionnaire) aggregated at 
group level. Furthermore, most longitudinal studies have 
employed relatively large intervals between assessments.
Despite previous literature reviews concluding that high FCR 
remains stable over time, data on BCS are not consistent and 
equivocal on this issue. Furthermore, clinical experts often 
report that in their practice many patients with high FCR 
experience fluctuations in their level of FCR over time. Known 
triggers of FCR include internal cues such as fatigue, pain, 
fever, and other somatic symptoms, or external cues such as 
medical investigations, reminders of cancer, cancer in the media, 
and hearing about cancer diagnosis in a friend or relative 
(Lee-Jones et  al., 1997; Custers et  al., 2017).
To date, only three studies involving women with breast 
cancer have investigated trajectories of FCR using prospective 
data or used more than three follow-up assessments to describe 
the course of FCR. A study by Dunn et  al. (2015) examined 
the trajectories of FCR of 396 women with breast cancer using 
monthly assessments of FCR in the first 6  months following 
breast cancer surgery. This study found that FCR scores declined 
significantly between the peri-operative period and 6  months 
after surgery, but that FCR scores plateau at approximately 
4  months. Women with better physical health and those with 
higher FCR scores at baseline reported a steeper decline in 
FCR scores. Despite a significant decrease in mean levels of 
FCR over the first 6 months after diagnosis, the authors identified 
there was considerable variation in the individual trajectories 
of FCR scores with some women describing a highly 
fluctuating course.
One additional study has documented the course of FCR 
over the first 18  months after diagnosis in a cohort of cancer 
survivors. Savard and Ivers (2013) surveyed a mixed sample 
of 962 cancer survivors (48% breast cancer) scheduled to 
undergo surgery on FCR peri-operatively and again 2, 6, 10, 
14, and 18  months later. FCR levels were found to be  highest 
at baseline, and significantly decreased at the 2-month evaluation 
but remained stable throughout the remainder of the study 
for patients with both clinical and sub-clinical FCR. Patients 
with high FCR at baseline continued to display high levels at 
all subsequent time points, suggesting a chronic course among 
those with elevated FCR at baseline.
Finally, a recent study of Yang et  al. (2018) examined FCR 
levels in a longitudinal design with breast cancer patients receiving 
radiotherapy (RT). Patients filled out a FCR questionnaire at 
their first day of treatment, and then weekly throughout the 
period of RT and 6–8  weeks after the end of treatment. Most 
women experienced a decline in fear during and after RT. 
However, there was considerable variation of trajectories observed. 
Initial level of FCR was the strongest predictor of follow-up 
FCR into the first 2  months of “survivorship” which, according 
Custers et al. Twelve Monthly Assessments of FCR
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to the authors, tended to support the view that FCR is quite 
stable and already present at the start of RT.
The results of the previous studies on the course of FCR 
suggest that FCR scores are highest in the peri-operative period 
followed by an initial decrease early in the treatment trajectory. 
However, despite some initial decrease, it appears that individuals 
with elevated FCR at baseline are likely to continue to have 
elevated FCR over the first 18  months post diagnosis. While 
together these studies provide valuable insight into the course 
of FCR, neither they do not identify the proportion of patients 
with a fluctuating course of FCR nor examine the course of 
FCR beyond the first 18  months after surgery.
The objective of this study was to describe the course of 
FCR in women with breast cancer 0–5  years post diagnosis. 
Specific aims were to assess:
 1. Whether significant differences in mean level of FCR occur 
when FCR is assessed monthly for 12  months (course 
of FCR).
 2. Whether distinct classes of individual trajectories of FCR 
can be  identified using a statistical approach.
 3. The proportion of women with a low and stable FCR 
(henceforth called “low FCR”), high and stable FCR (henceforth 
“high stable FCR”), and with levels of FCR which fluctuate 
above and below a validated cut-off (henceforth “fluctuating 
FCR”) using a more descriptive approach.
It was hypothesized that:
 a. Mean FCR scores would fluctuate over time when assessed 
at monthly intervals for 12  months.
 b. A higher proportion of women <3 years after surgery would 
have a fluctuating FCR or high FCR compared with those 
3–5  years post-surgery.
 c. The degree of FCR fluctuation in FCR scores would 
be  inversely associated with time since surgery. More 
specifically, a moderate to large negative correlation 
(r  =  >  0.3) between the absolute change in FCR score and 
time since surgery was predicted.
Since relatively little is known about how known triggers 
of FCR interact with the course of FCR, this study also sought 
to identify the self-reported triggers of FCR experienced by 




Institutional human ethics committee approval was obtained 
prior to commencement of the study (CMO Regio Arnhem-
Nijmegen, 2012/227). Potential participants were identified by 
searching the institutional databases of one academic and two 
regional hospitals in the Netherlands for women who met the 
eligibility criteria for this study. Eligible participants were: 
0–5  years after surgery for breast cancer; treated with curative 
intent and disease-free at the time of participation; and able 
to provide informed consent and read and write in Dutch. 
Eligible participants received a mailed invitation letter from 
their treating oncologist or surgeon explicitly stating that women 
both with and without elevated FCR could participate. Consenting 
participants received a monthly questionnaire for 12  months 
including demographic, medical, and psychosocial variables. 
Baseline questionnaires were completed in paper and pencil 
format, and subsequent questionnaires could either be  filled in 
online or in paper-and-pencil form according to participants’ 
preference. Of the 1,205 eligible women who were invited to 
the study, 565 (47%) were interested in receiving more information 
about the study and 460 (38%) consented. Study participants 
were compared to 539 non-responders (data of one regional 
hospital were not available) demonstrating that participants were 
significantly [t(993,635) = 5.77, p < 0.001] younger (M = 56.69, 
SD  =  9.6) than non-responders (M  =  60.64; SD  =  11.9).
Sample Sizes
To be  included in the statistical approach of class distinction 
(LCGA) which can handle missing data correctly, at least seven 
completed assessments and no more than two consecutive 
missing assessments were required. Therewith, longitudinal data 
of 377 patients were analyzed.
For the descriptive analysis in which it was not desirable 
to have missing data, patients with incomplete data for the 
Cancer Worry Scale (CWS) on any of the 12 time points were 
excluded resulting in a sample of 218 participants.
Measures
Clinical and Demographic Variables
Patients completed socio-demographic items assessing age, 
marital status, having children, education, and employment 
status as part of the baseline questionnaire. Clinical variables, 
including type of treatment and time since surgery, were self-
reported in the baseline questionnaire.
Fear of Cancer Recurrence
Fear of cancer recurrence severity was evaluated using the 
CWS. The CWS is used in research to assess concerns about 
developing cancer again and the impact of those concerns on 
daily functioning (Lerman et  al., 1991; Douma et  al., 2010). 
The eight items of the CWS are rated on a four-point Likert 
scale ranging from “never” to “almost always.” Scores range 
from 8 to 32. The CWS has been validated in Dutch women 
with breast cancer (Custers et  al., 2014). A cut-off score of 
14 or higher (sensitivity 77%; specificity 81%) has been validated 
in women with breast cancer indicating a high level of FCR 
and applied in this study (Custers et  al., 2014). In this study, 
the Cronbach’s alpha varied between 0.86 and 0.89.
Descriptive Classification of FCR Course
The course of FCR for each participant was classified using 
the following purpose-designed a priori criteria:
 a. Low stable: CWS score of 13 or lower at each assessment 
during the 12  month assessment period.
Custers et al. Twelve Monthly Assessments of FCR
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 b. High stable: CWS score of 14 or above at each assessment 
during the 12  month assessment period.
 c. Fluctuating: CWS scores both above and below cut-off for 
high FCR at subsequent assessments during the 12  month 
assessment period.
Triggers of FCR
The 12  month questionnaire asked participants to complete a 
short open-ended question “Has there been a particular situation 
or event that may have influenced the degree of fear that 
you  experience now?” immediately after completing the CWS.
Data Analysis
Absolute Change in FCR Scores (Total Delta)
To calculate the total magnitude of change in FCR scores over 
time, an absolute change score (delta) was calculated for each 
interval between months 1 to 12  in the data collection. A 
total absolute change score (total delta) was calculated by 
summation of the 11 monthly delta scores between months 
1 to 12.
Identification of Classes
Following the guidelines described by Jung and Wickrama 
(2008), latent class growth analysis (LCGA) was conducted 
using MPlus to identify trajectories (classes) over time for 
CWS scores. MPlus’ full information maximum likelihood 
estimation for handling missing data was applied. By estimating 
individual variability in outcome over time, individuals are 
classified into latent classes based upon similar patterns of FCR.
A single-class growth curve model, as well as a three-
class model was specified. To determine the number of classes 
in the sample, the three-class model was compared with a 
two-class and four-class model, as well as a five- and six-class 
model. In total, the fit of six unconditional latent class models 
(i.e., models with no covariates) was estimated, with one 
to six linear trajectories. The number of trajectories was 
determined based on model parsimony, fit indices, and clinical 
interpretability. The best fitting model has significant p-values 
(p  <  0.05) for the Bootstrap Likelihood Ratio Test (BLRT) 
and the Vuong-Lo-Mendell Ruben Likelihood Ratio Test 
(LMR-LRT), the smallest Bayesian Information Criterion 
(BIC), a higher entropy statistic (near 1.0), and higher 
posterior probabilities of group membership (near 1.0). The 
number of participants (not less than 5% of total sample) 
of the identified classes was considered for clinical 
interpretability.
Baseline Characteristics of Classes
Based on literature (Simard et  al., 2013), we compared a priori 
defined baseline demographic and medical characteristics between 
the identified classes using univariate and multivariate logistic 
regression analyses. First, univariate associations of baseline 
characteristics (age, partnered, children, education, employment, 
time since diagnosis, additional treatment, and satisfaction with 
medical treatment) with the classes of FCR were calculated. 
Next, to understand the independent contribution of the baseline 
characteristics, multivariate logistic regression analyses were 
conducted.
Latent class growth analysis was performed in Mplus 7 and 
the logistic regression analyses in SPSS version 25.
Classification of Low, Fluctuating, or High Stable 
FCR: Descriptive Approach
Chi-square was used to examine difference in the proportions 
of women who were classified as having low and stable, fluctuating, 
or chronically elevated FCR by time since surgery (<3 vs. 
3–5  years). Associations between absolute change in FCR (total 
delta) and time since diagnosis were explored using Pearson’s 
correlation. Differences in mean delta scores between women 
with a low, fluctuating, and high level of FCR were assessed 
with one way between groups ANOVA with post hoc contrasts.
Triggers of FCR
Reported triggers were independently coded for themes by 
two researchers. Coding was initially conducted using a priori 
codes derived from the triggers subscale of the FCR Inventory 
(FCRI; Simard and Savard, 2009). Initial coding was discussed 
by the research team, and where necessary codes were adapted 
or new codes added, following which both raters re-coded all 
responses and ratings were compared to check for inter-rater 
agreement (87%). Any further discrepancies were resolved 
through discussion until consensus was achieved.
RESULTS
Participant Characteristics
Longitudinal data of 377 patients were available for the statistical 
approach of class distinction. Demographics and medical 
characteristics of these participants are shown in Table  1.
For the descriptive analysis, a total of 218 women with 
complete CWS data were analyzed. Characteristics of the 
n  =  377 sample were comparable to the participants for the 
descriptive analysis (n  =  218): mean age was 58  years on 
average at baseline (range 33–87 years, SD = 9.4) and patients 
were on average 2.8  years post-diagnosis (range 0.5–5.9  years, 
SD = 1.4). The majority of participants was married or partnered 
(77%) and had children (82%). Approximately half (49%) had 
moderate education; one quarter had low (25%) and 
approximately one quarter (26%) higher education. Participants 
received a variety of adjuvant therapies including chemotherapy 
(65%), radiotherapy (78%), hormonal therapy (63%), and 
trastuzumab (10%).
Course of FCR
For the complete sample (N  =  377), the intercept of the CWS 
score generated with Mplus was 14.1 (95% CI 13.7–14.5), 
indicating moderate to high FCR. There was a slight decrease 
in CWS score (less FCR) over time (slope −0.07; 95% CI 
−0.09 to −0.04), equivalent to an average decrease in CWS 
score of −0.84 per year.
Custers et al. Twelve Monthly Assessments of FCR
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Identification of Classes: Statistical 
Approach
A three-class model was identified as most appropriate based 
on fit indices, internal reliability, and interpretability (Table 2). 
In the three-class model, compared with the two-class model, 
the BIC was better, but the entropy was lower. The posterior 
probabilities were similar for the two and three-class model. 
Compared with the four-class model, in the three-class model, 
the BIC was somewhat lower, whereas other fit indices were 
highly similar. In the four-class model, however, a subgroup 
was identified including only 10 patients, limiting 
clinical interpretability.
The three subgroups differed in the baseline values (intercepts) 
of the CWS scores. The first subgroup consisted of 149 participants 
and was defined as “low declining FCR,” as participants reported 
low baseline CWS scores (intercept 10.9; 95% CI 10.5–11.3), 
and the slope was −0.06 (95% CI −0.09 to −0.03). The second 
subgroup was defined as “moderate declining FCR,” as the 
177 participants in this group showed moderate to high baseline 
CWS scores (intercept 14.9; 95% CI 14.5–15.4), and the slope 
was −0.09 (95% CI −0.12 to −0.05). The third subgroup was 
defined as “high stable FCR.” For this subgroup of 51 patients, 
the intercept was 20.4 (95% CI 19.6–21.3), and the slope was 
non-significant (−0.03; 95% CI −0.13 to 0.06).
Baseline Characteristics of Classes
The results of the univariate and multivariate regression analyses 
comparing baseline characteristics of participants between the 
three FCR classes are shown in Table  3. Four variables (age, 
education, children, and satisfaction with medical treatment) 
were significantly different between groups in the univariate 
analysis and therefore selected to be  included in the final 
model with the low declining trajectory as the reference group. 
The final model was statistically significant (χ2 = 27.934, df = 8, 
p  <  0.001, Cox and Snell R2  =  0.074, Nagelkerke  =  0.086, and 
McFadden  =  0.039). Age, education, and satisfaction with 
medical treatment remained significant predictors of FCR 
trajectory. Younger patients (moderate declining OR  =  0.967; 
high stable OR  =  0.994), higher educated patients (moderate 
declining OR  =  1.954; high stable OR  =  2.083), and patients 
less satisfied with medical treatment (moderate declining 
OR  =  0.656; high stable OR  =  0.579) were more likely to 
belong to the moderate declining or stable high trajectory 
than the low declining trajectory.
Descriptive Course of FCR
Of the 218 women with CWS scores on all 12 assessments, 
approximately one-fifth of the sample (n = 45, 20.6%) reported 
low FCR at each monthly assessment (CWS scores 13 or lower). 
A similar proportion (n = 47, 21.6%) consistently scored above 
cut-off on the CWS (high FCR) at each time point, while the 
majority (n  =  126, 57.8%) reported scores which fluctuated 
above and below the validated CWS cut-off score for high 
FCR over 12 monthly assessments. No significant differences 
were observed in the proportion of women classified as low, 
fluctuating, or high CWS scores between those who were 
<3  years since surgery and women who were 3–5  years post-
surgery (χ2  =  1.68, p  =  0.43).
Mean CWS scores for the entire sample ranged from 13.2 
to 14.8 across the assessment period (12  months).
Absolute Change in FCR Scores Over 
12 Months
The median absolute change in CWS over 12 months (total delta) 
was 16 CWS points (M  =  17.5, SD  =  9.49, range  =  0–67). There 
was no association between total delta and time since diagnosis. 
TABLE 1 | Baseline characteristics of the identified subgroups of fear of cancer recurrence (FCR).
Total n = 377 Low declining  
FCR n = 149
Moderate declining  
FCR n = 177
High stable FCR n = 51
Demographics
Age, mean (SD), years* 57.6 (9.4) 58.8 (9.2) 56.2 (9.0) 58.9 (10.3) F(2,373) = 3,83, p = 0.02
Married/partnership, n (%) 280 (75%) 110 (74%) 129 (74%) 41 (80%) Χ2(2) = 0.89, p = 0.64
Children, n (%)* 313 (84%) 116 (78%) 150 (86%) 47 (92%) Χ2(2) = 6.26, p = 0.04
Education level*
High, n (%) 110 (30%) 55 (38%) 44 (25%) 11 (22%) Χ2(2) = 10.86, p = 0.03
Currently employed, n (%) 174 (46%) 68 (45%) 88 (50%) 18 (35%) Χ2(2) = 3.46, p = 0.18
Medical characteristics
Time since diagnosis, mean (SD), years 2.8 (1.3) 2.8 (1.3) 2.8 (1.3) 2.6 (1.3) F(2,365) = 0.492, p = 0.61
Additional treatment a
Chemotherapy, n (%) 267 (71%) 107 (73%) 124 (71%) 36 (71%) Χ2(2) = 0.23, p = 0.89
Radiotherapy, n (%) 289 (78%) 115 (78%) 136 (78%) 38 (75%) Χ2(2) = 0.31, p = 0.86
Hormonal therapy, n (%) 237 (63%) 90 (61%) 119 (68%) 28 (55%) Χ2(2) = 3.23, p = 0.19
Trastuzumab, n (%) 45 (12%) 18 (12%) 19 (11%) 8 (16%) Χ2(2) = 0.91, p = 0.64
Psychosocial factors
Satisfaction with medical treatment (0 
not at all–4 very satisfied)*
3.4 (0.7) 3.5 (0.7) 3.3 (0.7) 3.2 (0.9) F(2,370) = 4,79, p = 0.01
aDoes not sum to 100% as respondents could endorse multiple categories.  
*p < 0.05.
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TABLE 3 | Final model of baseline characteristics associated with subgroup 
membership for FCR, multinominal regression analysis for FCR (moderate 
declining worry and high stable worry vs. low declining worry).




−0.033 6.831 0.967 0.943–0.992




−0.432 1.898 0.650 0.352–1.200




0.670 6.947 1.954 1.187–3.215







−0.421 5.339 0.656 0.459–0.938
High stable −0.546 5.379 0.579 0.365–0.919
A one-way between-groups ANOVA was conducted to assess 
differences in mean delta scores between women with a low, 
fluctuating, and high level of FCR. There was a statistically 
significant difference between the groups: F(2, 215)  =  23.96, 
p  <  0.001. Post hoc comparisons indicated that the mean delta 
scores for the stable high (M  =  21.0, SD  =  8.5) and fluctuating 
group (M  =  18.9, SD  =  9.6) were significantly higher compared 
to the stable low group (M  =  9.7, SD  =  4.9).
Triggers of FCR
Fifty women (23%) reported an identifiable trigger at the final 
assessment. Trigger themes emerging from the data were: (1) 
medical appointments or examinations; (2) change of medication; 
(3) conversations about cancer or illness; (4) seeing or hearing 
about someone who is ill; (5) feeling unwell (physical symptoms); 
(6) funerals obituaries; or (7) other. The most commonly reported 
triggers were seeing or hearing about someone else who is unwell 
(reported 16 times), hearing of a death (12 times), or personally 
feeling unwell or experiencing physical symptoms (8 times). 
Women classified as having below cut-off CWS score (low FCR) 
at each assessment reported fewer triggers than those with high 
stable or fluctuating FCR, and many categories of triggers endorsed 
by women with high FCR or fluctuating FCR were not endorsed 
at all by those classified as having low FCR (e.g., physical 
symptoms, funerals, or obituaries).
DISCUSSION
The main finding of this study was that more than half (58%) 
of BCS in the present study reported CWS scores which 
fluctuated above and below a validated cut-off for high FCR 
at each monthly assessment over 12 months, while approximately 
one-fifth reported high scores and one-fifth reported low scores 
at all time points. These findings are partly in line with those 
of Savard and Ivers (2013) who found among a mixed cancer 
survivors group that patients with clinical FCR at baseline 
continued to display clinical levels at all subsequent time points.
Contrary to our hypothesis that fluctuation in CWS scores 
would decrease over time as women were expected to adjust 
to their breast cancer diagnosis, we  found no significant 
association between absolute change in CWS scores over 
12  months and time since diagnosis. Nor was a significant 
difference observed in the proportion reporting high, low, and 
fluctuating course up to 3  years post-surgery compared with 
3–5  years post-surgery, suggesting that fluctuation in FCR 
continues through the first 5  years after diagnosis. Therefore, 
compared to previous literature, the results of the present study 
suggest that high FCR may not be  as stable as it has been 
TABLE 2 | Fit indices, entropy, and average posterior probabilities across models with different number of classes with distinct trajectories of cancer worry.
No. of 
classes
BIC LMR-LRT BLRT Entropy n Posterior 
probabilities
Intercept (95% CI) Slope linear (95% CI)
























































BIC, bayesian information criterion; LMR-LRT, vuong-lo-mendell rubin likelihood ratio test; BLRT, bootstrap likelihood ratio test; and CI, confidence interval.
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previously characterized. Similar to the findings of Dunn et  al. 
(2015), our data indicated that individual fluctuation of FCR 
is common. Descriptive analysis of absolute change in CWS 
scores over 12  months and plots of individual FCR scores 
over time suggested that the FCR scores of those with low 
FCR remain relatively stable. Greater variability in FCR scores 
was observed in women who scored above cut-off at each 
monthly assessment (high and stable) and those whose scores 
fluctuated above and below cut-off at each monthly assessment 
(fluctuating). This level of variability in FCR scores seemed 
to be  characterized by the way survivors respond to triggers 
of FCR as triggers were more commonly reported by women 
who experienced high FCR at all time points and those with 
fluctuating levels of FCR. This could be  explained by the fact 
that high FCR is characterized by high levels of preoccupation 
and being less able to respond to triggers in an adaptive way. 
Although, the fluctuating group also pays attention to triggers 
they seem better able to adapt to and normalize accompanying 
feelings of FCR over time. Women with low FCR at all time 
points spontaneously reported fewer triggers of FCR, possibly 
due to less exposure to triggers, paying less attention to triggers 
or finding them less bothersome.
Regarding the nature of triggers, in accordance with the 
theoretical model of Lee-Jones et  al. (1997) and Custers et  al. 
(2017), both external (seeing or hearing about someone else 
who is unwell) and internal triggers (personally feeling unwell 
or experiencing physical symptoms) were reported. This nature 
of triggers might also be related to the culture in the Netherlands 
with a lot of media attention on (breast) cancer (e.g., breast 
cancer month), regular medical check-ups, national screening 
programs for breast cancer, and most people speaking openly 
about cancer.
Strength of this data was that it included assessment of 
triggers for current rating of FCR rather than retrospective 
recall of triggers as has been used in most previous studies. 
However, a potential limitation was that women who use 
avoidance-based strategies for managing FCR may also have 
avoided participating and or answering these questions given 
they were optional and less than one quarter of the sample 
could identify specific triggers. Research concerning triggers 
of FCR is currently very limited but it is of high relevance 
to developing evidence-based theoretical models of FCR (Fardell 
et  al., 2016; Custers et  al., 2017; Simonelli et  al., 2017) and 
improving our understanding of the evolution of FCR.
Results of the LCGA confirmed the three-class approach 
including a stable high FCR group (13%), a low group (40%), 
and a moderate group (47%). Both the moderate and low 
scoring groups reported declining scores over time. The moderate 
group might be  interpreted as fluctuating with a moderate-
to-high intercept of 14.9 and a slope of −0.009 resulting in 
a decrease of 0.11 per year, continuing around the cut-off 
score. Compared with patients in the low declining FCR group, 
younger patients, higher educated patients, and those less 
satisfied with the medical treatment were more likely to belong 
to the moderate declining or high stable trajectory. These 
predictors are in line with the review of Simard et  al. (2013) 
showing moderate to strong evidence for poor healthcare 
satisfaction and younger age as predictors for FCR. Findings 
on education as predictor for FCR remained inconclusive.
Strengths and Limitations
One of the strengths of this study is its use of a statistical 
(bottom-up) as well as descriptive (top-down) approach to 
correctly identify trajectories of FCR. Both approaches revealed 
three distinct trajectories of FCR, enhancing its validity and 
clinical interpretability. However, by interpreting the results, 
it is important to keep in mind that this was not an inception 
cohort, only linear trajectories were assessed and although the 
descriptive analysis was based on a validated cut-off score for 
high FCR, we  acknowledge that the selected cut-off has not 
been validated against a gold-standard interview for clinical 
FCR. Furthermore, since participants were aware of the fact 
that the purpose of the study was FCR, it is plausible that 
there was a selection in signups for the study as confirmed 
by the moderate response rate of 38%. Selection bias is an 
aspect that should be  taken into account when designing 
research on FCR since a proportion of survivors recognizes 
their FCR and expresses a need for help; whereas, other survivors 
cope with FCR by avoiding threat, including study questionnaires.
Implications and Future Research
Current interventions for FCR are mostly offered on the 
basis of a score above cut-off for high FCR on a single 
screening occasion (Butow et al., 2013; Van de Wal et al., 2017). 
An important clinical implication of the present findings is 
that FCR should be  assessed on multiple occasions before 
a healthcare professional decides that new evidence-based 
clinical interventions for FCR are warranted. A stepped-care 
model with a first stage of intervention, which may include 
watchful waiting, psycho-education, online interventions, or 
other self-management approaches might be  appropriate. If 
FCR does not dissipate after an initial waiting period or 
period of less intensive intervention, more intensive face-to-face 
interventions could be  offered. Such a model has  been 
effectively used in a hospital setting (Krebber et al., 2012, 2016) 
and may produce cost-savings for the health system, and 
help ensure that limited resources are directed to those most 
in need. The results of the present study also have relevance 
for emerging trials of FCR interventions, and raise the 
question whether the results observed might simply reflect 
the natural fluctuations in FCR over relatively short intervals 
(3–4  months).
There is growing interest in the use of novel research methods 
using very frequent assessment of symptoms (e.g., ecological 
momentary assessment). ESM is a method in which participants 
are asked to rate their situations, emotions, and reactions at 
random moments during the day for multiple days 
(Csikszentmihalyi and Larson, 2014). Compared with 
retrospective questionnaires which often assess constructs “over 
the past week,” ESM offers several advantages: enhanced ecological 
validity because participants are assessed in their normal daily 
environment, minimized retrospective bias because participants’ 
experiences are assessed in the moment, and enhanced reliability 
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because participants’ are assessed repeatedly. Assessment of 
FCR using ESM might be  a valuable approach for future 
research since frequent reassessment of FCR will provide further 
insights into the evolution of FCR and may prove useful in 
future trials evaluating FCR interventions. For researchers, the 
results of the present study suggest that future longitudinal 
studies should consider assessing FCR on multiple (>2) time-
points and to consider shorter durations between assessments 
in order to capture potential variability. A better understanding 
of the evolution of FCR will help guide the implementation 
of evidence-based treatments for FCR.
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